Karen Fink

Karen Fink

UNVERIFIED PROFILE

Are you Karen Fink?   Register this Author

Register author
Karen Fink

Karen Fink

Publications by authors named "Karen Fink"

Are you Karen Fink?   Register this Author

38Publications

964Reads

39Profile Views

Adult Primary Peripheral PNET/Ewing's Sarcoma of the Cervical and Thoracic Spine.

Anticancer Res 2019 Aug;39(8):4463-4465

UT Southwestern Medical Center, Dallas, TX, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.13619DOI Listing
August 2019

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

J Transl Med 2018 06 29;16(1):179. Epub 2018 Jun 29.

Northwest Biotherapeutics Inc., Bethesda, MD, USA.

View Article

Download full-text PDF

Source
https://translational-medicine.biomedcentral.com/articles/10
Publisher Site
http://dx.doi.org/10.1186/s12967-018-1552-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026340PMC
June 2018

Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study.

Neuro Oncol 2015 May 11;17(5):708-17. Epub 2015 Mar 11.

University of Alabama at Birmingham, Birmingham, Alabama (L.B.N.); Baylor University Medical Center, Dallas, Texas (K.L.F.); Henry Ford Hospital, Detroit, Michigan (T.M.); Clinic for Neurosurgery, Clinical Center of Serbia, Medical Faculty University of Belgrade, Belgrade, Serbia (D.G.); Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch, Radiotherapy and Chemotherapy Clinic, Gliwice, Poland (R.T.); Samsung Medical Center, Seoul, South Korea (D.H.N.); Centrum Onkologii Ziemi Lubelskiej, Lublin, Poland (M.M.); St. Luke's Brain Tumor Center, St. Luke's Hospital, Kansas City, Missouri (M.S.); Barrow Neurological Institute, Phoenix, Arizona (L.A.); Medical Oncology Unit 1, IOV, IRCCS, Padova, Italy (V.Z.); Policlinico di Modena, Modena, Italy (R.D.); Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (J.R.P.); Merck KGaA, Darmstadt, Germany (C.H., M.P.); Department of Clinical Neurosciences, University Hospital Lausanne, Lausanne, Switzerland (M.E.H.); Institute of Pathology, University Hospital Lausanne, Lausanne, Switzerland (B.L.); Dana-Farber Cancer Institute, Boston, Massachusetts (D.A.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou356DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482861PMC
May 2015

Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH.

J Clin Oncol 2014 Mar 10;32(8):783-90. Epub 2014 Feb 10.

J. Gregory Cairncross, University of Calgary, Calgary, Alberta; Luis Souhami, McGill University, Montreal, Quebec; Normand J. Laperriere, University of Toronto, Toronto, Ontario, Canada; Meihua Wang, American College of Radiology, Philadelphia, PA; Robert B. Jenkins, Caterina Giannini, and Jan C. Buckner, Mayo Clinic, Rochester, MN; Edward G. Shaw, Wake Forest School of Medicine, Winston-Salem, NC; David G. Brachman, Arizona Oncology Services Foundation/Barrow Neurological Institute, Phoenix, AZ; Karen L. Fink, Baylor University, Dallas, TX; Jason T. Huse, Memorial Sloan-Kettering Cancer Center, New York, NY; Minesh P. Mehta, Northwestern University, Chicago, IL; and Walter J. Curran Jr, Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.3726DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940537PMC
March 2014

Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study.

Cancer Chemother Pharmacol 2008 May 11;61(6):1059-67. Epub 2007 Aug 11.

Department of Neurological Surgery, University of California San Francisco, 400 Parnassus Ave., Room 808, San Francisco, CA 94143-0372, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-007-0556-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873156PMC
May 2008

A volumetric study of CyberKnife hypofractionated stereotactic radiotherapy as salvage for progressive malignant brain tumors: initial experience.

Neurol Res 2007 Sep;29(6):563-8

Baylor Radiosurgery Center, Baylor University Medical Center, Dallas, TX 75246, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1179/016164107X166245DOI Listing
September 2007